Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 Jun 28, 2018 424B5
424B5 Jun 27, 2018 424B5
8-K Jun 25, 2018 8-K
4 Jun 7, 2018 FORM 4 SUBMISSION
4 Jun 7, 2018 FORM 4 SUBMISSION
4 Jun 7, 2018 FORM 4 SUBMISSION
4 Jun 7, 2018 FORM 4 SUBMISSION
4 Jun 7, 2018 FORM 4 SUBMISSION
4 Jun 7, 2018 FORM 4 SUBMISSION
4 Jun 7, 2018 FORM 4 SUBMISSION
3 Jun 7, 2018 FORM 3 SUBMISSION
8-K Jun 7, 2018 FORM 8-K
4 May 30, 2018 FORM 4 SUBMISSION
3 May 30, 2018 FORM 3 SUBMISSION
8-K May 30, 2018 8-K
10-Q May 10, 2018 10-Q
8-K May 8, 2018 8-K
DEF 14A Apr 18, 2018 DEF 14A
4 Mar 9, 2018 FORM 4 SUBMISSION
S-8 Mar 9, 2018 S-8
10-K Mar 9, 2018 10-K
8-K Mar 6, 2018 8-K
4 Feb 23, 2018 FORM 4 SUBMISSION
4 Feb 23, 2018 FORM 4 SUBMISSION
4 Feb 23, 2018 FORM 4 SUBMISSION
← Newer Page 18 of 28 · 696 filings Older →